Stark, Catherine
Stark, Richard
Limberg, Nicole
Rodrigues, Julian
Cordato, Dennis
Schwartz, Raymond
Jukic, Robert
Article History
Received: 15 March 2019
Accepted: 3 July 2019
First Online: 15 July 2019
Ethics approval and consent to participate
: This study was conducted in accordance with the International Council for Harmonisation Guidelines on Good Clinical Practice and in accordance with the National Statement on Ethical Conduct in Human Research 2007 (updated May 2015). Investigators were required to obtain approval from a properly constituted Human Research Ethics Committee at their institutions prior to initiating the study.
: Not applicable.
: CS has received a previous travel grant from Allergan and has received advisory board and/or lecture fees from Allergan, Novartis, and SciGen. RSta has received advisory board and/or lecture fees from Allergan, Biogen, Eli Lilly, Novartis, SciGen, and Teva. NL has received partial funding for a clinical nurse and a travel grant from Allergan, advisory board fees from Novartis, and a clinical trial grant from Teva. JR has received travel grants and nurse funding from Allergan and advisory board fees from Allergan, Novartis, and Teva. DC and RSch have nothing to disclose. RJ is an employee of Allergan.